[Incidence and management of chemotherapy-induced nausea and vomiting in women with breast cancer]

Rev Gaucha Enferm. 2014 Sep;35(3):117-23. doi: 10.1590/1983-1447.2014.03.42068.
[Article in Portuguese]

Abstract

The objective of this study was to analyze the incidence of chemotherapy-induced nausea and vomiting in women with breast cancer and identify strategies used by them to control these signs and symptoms. Data for this cross-sectional study were collected through interviews during the last cycle of chemotherapy, between August 2011 and March 2012, in a university hospital in the State of São Paulo. The sample consisted of 22 women between the ages of 31 and 70, of whom 77.3% reported nausea and 50% vomiting during treatment. Regarding symptom management, 82% of the women reported having received some information centered on the use of prescribed medication. However, 27.3% did not know what medication they had taken. We concluded that there is a lack of systematic care and institutional protocol to guide professionals in providing standardized information to women so they can better control nausea and vomiting.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Antiemetics / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Cross-Sectional Studies
  • Female
  • Humans
  • Incidence
  • Middle Aged
  • Nausea / chemically induced
  • Nausea / drug therapy*
  • Nausea / epidemiology*
  • Vomiting / chemically induced
  • Vomiting / drug therapy*
  • Vomiting / epidemiology*

Substances

  • Antiemetics